A randomized, double-blind, placebo-controlled clinical trial on once-daily atomoxetine in Taiwanese children and adolescents with attention-deficit/hyperactivity disorder.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples